Press Releases on March 4, 2024 - EIN Presswire - Press Release Distribution Service

Published on March 4, 2024 - 13:00 GMT

Navitas Credit Corporation names Robert Hill senior vice president, finance as John Paris announces retirement

United Community Banks, Inc. (NASDAQ:UCBI) GREENVILLE, SOUTH CAROLINA, UNITED STATES, March 4, 2024 /⁨EINPresswire.com⁩/ -- Navitas Credit Corp., an industry leader in equipment financing and a wholly owned subsidiary of United Community (NASDAQ: UCBI), …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on March 4, 2024 - 13:00 GMT

aiXplain Accelerates Commercial Strategy with Key Leadership Appointments

aiXplain Welcomes Latif Nathani (COO), Husni Khuffash (MD of MENA), and Steven Hartman (Head of Marketing) SAN JOSE, CALIFORNIA, UNITED STATES OF AMERICA, March 4, 2024 /⁨EINPresswire.com⁩/ -- aiXplain, the leader in empowering developers and business …

Distribution channels: Technology ...

Published on March 4, 2024 - 13:00 GMT

Dr. Robert Stoner of MIT joins the Advisory Board of Energy Internet Corporation

EIC welcomes Dr.Stoner as xLDES commercialization approaches. SAN JOSE, CALIFORNIA, USA, March 4, 2024 /⁨EINPresswire.com⁩/ -- Energy Internet Corporation is pleased to welcome MIT physicist Dr. Robert Stoner to its growing board of expert advisors to …

Distribution channels: Business & Economy, Energy Industry ...

Published on March 4, 2024 - 13:00 GMT

Workplace Transformation Market Driven by Shift Towards Remote and Hybrid Work Models

Shift towards remote and hybrid work models drives growth in the Workplace Transformation Market, offering digital collaboration solutions. AUSTIN, TEXAS, UNITED STATES, March 4, 2024 /⁨EINPresswire.com⁩/ -- Market Report Scope & Overview In the …

Distribution channels: IT Industry ...

Published on March 4, 2024 - 13:00 GMT

ASML reports transactions under its current share buyback program

ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted …

Distribution channels: Media, Advertising & PR, Technology ...

Published on March 4, 2024 - 13:00 GMT

STMicroelectronics Announces Status of Common Share Repurchase Program

STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from Feb 26, 2024 to Mar 01, 2024 AMSTERDAM – March 4, 2024 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a …

Distribution channels: Media, Advertising & PR, Technology ...

Published on March 4, 2024 - 13:00 GMT

MoonLake Immunotherapeutics to present MIRA trial data of Nanobody® sonelokimab in hidradenitis suppurativa as a late breaker at ...

MoonLake Immunotherapeutics to present MIRA trial data of Nanobody® sonelokimab in hidradenitis suppurativa as a late breaker at the AAD Annual Meeting 2024 ZUG, Switzerland, March 4, 2024 – MoonLake Immunotherapeutics (“MoonLake”; Nasdaq: MLTX), a …

Distribution channels: Media, Advertising & PR, Technology ...

Published on March 4, 2024 - 13:00 GMT

Sodexo joins the “World Most Ethical Companies®” recognized by Ethisphere

Sodexo joins the “World Most Ethical Companies®” recognized by Ethisphere Issy-les-Moulineaux, March 4th, 2024 Sodexo is very proud to announce its presence among the “2024 World’s Most Ethical Companies®” for the first time. This list, issued by …

Distribution channels: Food & Beverage Industry, Media, Advertising & PR ...

Published on March 4, 2024 - 13:00 GMT

Sodexo intègre le classement des « Entreprises les Plus Éthiques au Monde® » de l’institut Ethisphere

Sodexo intègre le classement des « Entreprises les Plus Éthiques au Monde® » de l’institut Ethisphere Issy-les-Moulineaux, 4 mars 2024 Sodexo est très fier d’annoncer son entrée au classement 2024 des « Entreprises les Plus Éthiques au Monde® ». Établie …

Distribution channels: Food & Beverage Industry, Media, Advertising & PR ...

Published on March 4, 2024 - 13:00 GMT

Tome Biosciences Forms Science and Technology Advisory Committee

WATERTOWN, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Tome Biosciences, Inc., the programmable genomic integration (PGI) company, announces the formation of its Science and Technology Advisory Committee (STAC) comprised of four leaders in the delivery, …

Distribution channels:

Published on March 4, 2024 - 13:00 GMT

4DMT to Participate in Upcoming Investor Conferences

EMERYVILLE, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat large market …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on March 4, 2024 - 13:00 GMT

Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences: Barclays 26th Annual Global …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on March 4, 2024 - 13:00 GMT

Lisata Therapeutics to Present at the Life Science Investor Forum on March 7ᵗʰ

BASKING RIDGE, N.J., March 04, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other …

Distribution channels:

Published on March 4, 2024 - 13:00 GMT

Aruna BIO Establishes Stroke Advisory Board to Advance Lead Program, AB126 into the Clinic

-The Stroke Advisory Board brings together distinguished experts in neurology and stroke to support the advancement of its neural exosome platform and lead program– -Phase 1b/2a clinical trial in acute ischemic stroke expected to initiate in 2H 2024; AB126 …

Distribution channels: Media, Advertising & PR, Technology ...

Published on March 4, 2024 - 13:00 GMT

Osmol Therapeutics Appoints Ron Weitzman, M.D., as Interim Chief Medical Officer

NEW HAVEN, Conn., March 04, 2024 (GLOBE NEWSWIRE) -- Osmol Therapeutics, a privately held clinical-stage biopharmaceutical company focused on developing preventative treatments for chemotherapy-induced peripheral neuropathy (CIPN) and chemotherapy-induced …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on March 4, 2024 - 13:00 GMT

Immuneering to Participate in the Cowen 44th Annual Health Care Conference

CAMBRIDGE, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for broad populations of cancer patients, today announced that …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on March 4, 2024 - 13:00 GMT

Insiders Confident CLM is Ready for Growth

TORONTO, March 04, 2024 (GLOBE NEWSWIRE) -- Consolidated Lithium Metals Inc. (TSXV: CLM | OTCQB: JORFF | FRA: Z36) (“CLM” or the “Company“) is pleased to announce an aggregate purchase of 6 million common shares of the Company by three of its senior …

Distribution channels: ...

Published on March 4, 2024 - 13:00 GMT

Banzai to Participate in the 36th Annual ROTH Conference

SEATTLE, March 04, 2024 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, is scheduled to participate in the 36th Annual …

Distribution channels:

Published on March 4, 2024 - 13:00 GMT

NKGen Biotech Announces Upcoming Presentation on SNK01 in Alzheimer’s Disease at the Tau2024 Global Conference

SANTA ANA, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on March 4, 2024 - 13:00 GMT

Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024

DURHAM, N.C., March 04, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal year …

Distribution channels: